Evidence map›Paper›PMID 29333515›Full record

Observational studyInvestigative and clinical urology2018

Changes in autonomic nervous system activity after treatment with alpha-blocker in men with lower urinary tract symptoms.

Kang Hee Shim, Tae Woo Kim, Byung Ha Chung, Sung Won Lee, Jong Kwan Park, Kwangsung Park, Jun Cheon, Kyung Seop Lee, Hyung-Jee Kim, Do-Hwan Seong and 5 more

Open access · diamondAbstract readObservational Study
In one paragraph

Observational study in Investigative and clinical urology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 11 institutions in 1 country.

Kang Hee ShimDepartment of Urology, Ajou University College of Medicine, Suwon, Korea.
Tae Woo KimDepartment of Urology, Ajou University College of Medicine, Suwon, Korea.
Byung Ha ChungDepartment of Urology and Urological Science Institute, Yonsei University College of Medicine, Seoul, Korea.
Sung Won LeeDepartment of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Jong Kwan ParkDepartment of Urology, Chonbuk National University School of Medicine, Jeonju, Korea.
Kwangsung ParkDepartment of Urology, Chonnam National University Medical School, Gwangju, Korea.
Jun CheonDepartment of Urology, Korea University Anam Hospital, Seoul, Korea.
Kyung Seop LeeDepartment of Urology, Dongguk University College of Medicine, Gyeongju, Korea.
Hyung-Jee KimDepartment of Urology, Dankook University College of Medicine, Cheonan, Korea.
Do-Hwan SeongDepartment of Urology, Inha University College of Medicine, Incheon, Korea.
Seung-June OhDepartment of Urology, Seoul National University Hospital, Seoul, Korea.
Sae Woong KimDepartment of Urology, The Catholic University of Korea College of Medicine, Seoul, Korea.
Ji Youl LeeDepartment of Urology, The Catholic University of Korea College of Medicine, Seoul, Korea.
Seol Ho ChooDepartment of Urology, Ajou University College of Medicine, Suwon, Korea.
Jong Bo ChoiDepartment of Urology, Ajou University College of Medicine, Suwon, Korea.ORCID 0000-0002-6474-9913
Ajou University · KRCatholic University of Korea · KRChonnam National University Hospital · KRDankook University · KRDongguk University · KRInha University · KRJeonbuk National University · KRKorea University Medical Center · KRSamsung Medical Center · KRSeoul National University Hospital · KRYonsei University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: To determine changes in autonomic nervous system activity after treatment in men with lower urinary tract symptoms (LUTS), we evaluated changes in patients' symptoms, uroflowmetry, and heart rate variability (HRV) after treatment with alpha-blockers for 12 weeks. Materials and Methods: Ninety-five men who had LUTS (International Prostate Symptom Score [IPSS] ≥8) were included in this study. We divided them into two groups on the basis of a low frequency/high frequency (LF/HF) ratio of 1.6. After treatment with Xatral XL (Handok Inc., Korea) 10 mg for 3 months, we rechecked their IPSS, uroflowmetry, HRV and compared these with the baseline measurements. Results: Fifty-four men were assigned to the low LF/HF group (group A: LF/HF ≤1.6) and 41 men to the high LF/HF group (group B: LF/HF >1.6). At baseline and 12 weeks, none of the parameters differed significantly between the groups except for HF, which is one of the parameters of HRV. IPSS, the IPSS-voiding subscore, and the IPSS-storage subscore decreased and maximal uroflow increased significantly after 12 weeks of treatment. Whereas the baseline LF/HF ratio increased from 0.89±0.407 to 1.80±1.804 after treatment in group A, it decreased from 3.93±5.471 to 1.79±1.153 in group B. Conclusions: The efficacies of Xatral XL were clear in both groups. We found that the LF/HF ratio in the two groups merged to a value of approximately 1.79 after treatment. We suggest that this could be a clue to the importance of balance in autonomic nervous system activity in men with LUTS.

Indexed as

Adrenergic alpha-AntagonistsAgedAutonomic Nervous SystemHeart RateHumansLower Urinary Tract SymptomsMaleMiddle AgedQuinazolinesUrinationUrodynamicsUrological AgentsAdrenergic alpha-AntagonistsalfuzosinQuinazolinesUrological AgentsAutonomic nervous systemProstateUrination

Identifiers

PMID29333515
PMCPMC5754583
OpenAlexW2782282052

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.